Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?

Related Articles

Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?

Thromb Res. 2016 Jul;143:101-2

Authors: Chalayer E, Chapelle C, Leleu X, Elalamy I, Laporte S, Tardy B

PMID: 27208979 [PubMed - indexed for MEDLINE]

http://ift.tt/2pgs2JD